A recurrent mutation in PALB2 in Finnish cancer families

Hannele Erkko, Bing Xia, Jenni Nikkilä, +24

Nature

Recurrent MutationSomatic VariantGeneticsPathologyCancer Genomics +4

Penetrance Analysis of the <i>PALB2</i> c.1592delT Founder Mutation

Hannele Erkko, James G. Dowty, Jenni Nikkilä, +12

Clinical Cancer Research

Familial breast cancer screening reveals an alteration in the RAP80 UIM domain that impairs DNA damage response function

Janne Nikkilä, Karissa Coleman, Dylan Morrissey, +7

Oncogene

Cancer ResearchGenome InstabilityBreast OncologyMedicineGenetics +9

Association of common <i>ATM</i> polymorphism with bilateral breast cancer

Katri Heikkinen, Katrin Rapakko, Sanna‐Maria Karppinen, +3

International Journal of Cancer

Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer families

Katri Pylkäs, Hannele Erkko, Jenni Nikkilä, +2

BMC Cancer

Nordic collaborative study of the <i>BARD1</i> Cys557Ser allele in 3956 patients with cancer: enrichment in familial <i>BRCA1</i>/<i>BRCA2</i> mutation-negative breast cancer but not in other malignancies

Sanna‐Maria Karppinen, Rósa B. Barkardóttir, Katja Backenhorn, +20

Journal of Medical Genetics

Identification of a common polymorphism in the TopBP1 gene associated with hereditary susceptibility to breast and ovarian cancer

Sanna‐Maria Karppinen, Hannele Erkko, Kaarina Reini, +5

European Journal of Cancer

Breast OncologyGeneticsGenetic EpidemiologyHereditary SusceptibilityPathology +8

Germline alterations in the CLSPN gene in breast cancer families

Hannele Erkko, Katri Pylkäs, Sanna‐Maria Karppinen, +1

Cancer Letters

Breast OncologyMedicineGeneticsPathologyCancer Genomics +7

Germline alterations in the 53BP1 gene in breast and ovarian cancer families

Katrin Rapakko, Katri Heikkinen, Sanna‐Maria Karppinen, +2

Cancer Letters

Breast OncologyGeneticsGermline AlterationsCancer GenomicsBreast Cancer +7

Mutation analysis of the AATF gene in breast cancer families

Maria K. Haanpää, Mervi Reiman, Jenni Nikkilä, +3

BMC Cancer